Home>
US Stocks>
Bausch Health Companies

Bausch Health Companies share price today

(BHC)

Bausch Health Companies share price is $7.58 & -₹7.58 as on 12 Dec 2024, 2.30 'hrs' IST

$7.58

▲

-0.74

(-8.89%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Bausch Health Companies share price in Dollar and Rupees. Guide to invest in Bausch Health Companies from India. Also see the sentimental analysis on Indian investors investing in Bausch Health Companies. Get details on the Indian mutual funds that are investing in Bausch Health Companies. Get Analyst recommendations and forecasts along with all the Bausch Health Companies's financials.

Bausch Health Companies share price movements

$7.42
$7.87
$7.58
2.11%
Downside
Day's Volatility :5.72%
Upside
3.68%
$3.96
$11.46
$7.58
47.76%
Downside
52 Weeks Volatility :65.45%
Upside
33.86%

Bausch Health Companies Returns

Period	Bausch Health Companies Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	20.32%	-8.8%	0.0%
6 Months	22.85%	-2.7%	0.0%
1 Year	0.93%	6.5%	0.0%
3 Years	-68.56%	5.6%	-20.0%

Bausch Health Companies Key Statistics

in dollars & INR

Previous Close	$8.32
Open	$8.1
Today's High	$7.87
Today's Low	$7.42
Market Capitalization	$3.1B
Today's Volume	$1.1M
52 Week High	$11.46
52 Week Low	$3.96
Revenue TTM	$9.5B
EBITDA	$3.1B
Earnings Per Share (EPS)	$-0.48
Profit Margin	-1.88%
Quarterly Earnings Growth YOY	-0.61%
Return On Equity TTM	-2304.54%

How to invest in Bausch Health Companies from India?

It is very easy for Indian residents to invest directly in Bausch Health Companies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bausch Health Companies stock in both rupees (INR) and dollars (USD). Search for Bausch Health Companies or BHC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bausch Health Companies or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bausch Health Companies shares which would translate to -0.001 fractional shares of Bausch Health Companies as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Bausch Health Companies

-3%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Bausch Health Companies on INDmoney from India has reduced in the last 30 days as on Dec 12, 2024. -3% less investors are searching Bausch Health Companies in the last 30 days versus the previous period.

Global Institutional Holdings in Bausch Health Companies

ICAHN CARL C
9.44%
Goldentree Asset Management LP
7.99%
Paulson & Company Inc
7.19%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
3.53%
Vanguard Group Inc
3.14%
Nomura Holdings Inc
3.08%

Analyst Recommendation on Bausch Health Companies

Hold

0%Buy

60%Hold

40%Sell

Based on 10 Wall street analysts offering stock ratings for Bausch Health Companies(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bausch Health Companies

What analysts predicted

Upside of 13.08%

Current:

$7.58

Target:

$8.57

Insights on Bausch Health Companies

Price Movement
In the last 7 days, BHC stock has moved down by -6.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 2.14B → 2.51B (in $), with an average increase of 7.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 10.0M → -85.0M (in $), with an average decrease of 950.0% per quarter
BHC vs CTLT (1 yr)
In the last 1 year, Catalent, Inc. has given 69.5% return, outperforming this stock by 63.8%
BHC vs NBIX (3 yr)
In the last 3 years, Bausch Health Companies Inc has experienced a drawdown of -68.9%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 20.6%
Price to Sales
ForBHC every $1 of sales, investors are willing to pay $0.3, whereas for Catalent, Inc., the investors are paying $2.6 for every $1 of sales.

Bausch Health Companies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$8.4B	↓ 3.94%
Net Income	$-4.1B	↓ 272.55%
Net Profit Margin	-49.5%	↓ 77.06%

	FY19	Y/Y Change
Revenue	$8.6B	↑ 2.64%
Net Income	$-1.8B	↓ 57.02%
Net Profit Margin	-20.73%	↑ 28.77%

	FY20	Y/Y Change
Revenue	$8.0B	↓ 6.67%
Net Income	$-559.0M	↓ 68.65%
Net Profit Margin	-6.96%	↑ 13.77%

	FY21	Y/Y Change
Revenue	$8.4B	↑ 5.07%
Net Income	$-937.0M	↑ 67.62%
Net Profit Margin	-11.11%	↓ 4.15%

	FY22	Y/Y Change
Revenue	$8.1B	↓ 3.68%
Net Income	$-212.0M	↓ 77.37%
Net Profit Margin	-2.61%	↑ 8.5%

	FY23	Y/Y Change
Revenue	$8.8B	↑ 7.79%
Net Income	$-592.0M	↑ 179.25%
Net Profit Margin	-6.76%	↓ 4.15%

	Q2 FY23	Q/Q Change
Revenue	$2.2B	↑ 11.47%
Net Income	$26.0M	↓ 112.44%
Net Profit Margin	1.2%	↑ 11.95%

	Q3 FY23	Q/Q Change
Revenue	$2.2B	↑ 3.28%
Net Income	$-378.0M	↓ 1553.85%
Net Profit Margin	-16.89%	↓ 18.09%

	Q4 FY23	Q/Q Change
Revenue	$2.4B	↑ 7.6%
Net Income	$395.0M	↓ 204.5%
Net Profit Margin	16.4%	↑ 33.29%

	Q1 FY24	Q/Q Change
Revenue	$2.1B	↓ 10.99%
Net Income	$-63.7M	↓ 116.13%
Net Profit Margin	-2.97%	↓ 19.37%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 12.09%
Net Income	$10.0M	↓ 115.7%
Net Profit Margin	0.42%	↑ 3.39%

	Q3 FY24	Q/Q Change
Revenue	$2.5B	↑ 4.47%
Net Income	$-85.0M	↓ 950.0%
Net Profit Margin	-3.39%	↓ 3.81%

	FY18	Y/Y Change
Total Assets	$27.4B	↓ 26.8%
Total Liabilities	$24.6B	↓ 21.93%

	FY19	Y/Y Change
Total Assets	$33.9B	↑ 23.38%
Total Liabilities	$32.7B	↑ 32.86%

	FY20	Y/Y Change
Total Assets	$31.2B	↓ 7.87%
Total Liabilities	$30.6B	↓ 6.52%

	FY21	Y/Y Change
Total Assets	$29.2B	↓ 6.4%
Total Liabilities	$29.2B	↓ 4.44%

	FY22	Y/Y Change
Total Assets	$25.7B	↓ 12.04%
Total Liabilities	$25.4B	↓ 13.03%

	FY23	Y/Y Change
Total Assets	$27.4B	↑ 6.48%
Total Liabilities	$27.4B	↑ 7.89%

	Q2 FY23	Q/Q Change
Total Assets	$33.8B	↑ 32.82%
Total Liabilities	$33.4B	↑ 32.16%

	Q3 FY23	Q/Q Change
Total Assets	$27.1B	↓ 19.92%
Total Liabilities	$27.3B	↓ 18.36%

	Q4 FY23	Q/Q Change
Total Assets	$27.4B	↑ 1.06%
Total Liabilities	$27.4B	↑ 0.49%

	Q1 FY24	Q/Q Change
Total Assets	$26.9B	↓ 1.7%
Total Liabilities	$27.1B	↓ 1.36%

	Q2 FY24	Q/Q Change
Total Assets	$26.5B	↓ 1.47%
Total Liabilities	$26.7B	↓ 1.26%

	Q3 FY24	Q/Q Change
Total Assets	$26.5B	↑ 0.18%
Total Liabilities	$26.8B	↑ 0.24%

	FY18	Y/Y Change
Operating Cash Flow	$1.5B	↓ 34.45%
Investing Cash Flow	$-196.0M	↓ 106.79%
Financing Cash Flow	$-1.4B	↓ 72.74%

	FY19	Y/Y Change
Operating Cash Flow	$1.5B	↑ 0.0%
Investing Cash Flow	$-419.0M	↑ 113.78%
Financing Cash Flow	$1.4B	↓ 206.65%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 25.98%
Investing Cash Flow	$-261.0M	↓ 37.71%
Financing Cash Flow	$-2.3B	↓ 258.97%

	FY21	Y/Y Change
Operating Cash Flow	$1.4B	↑ 28.35%
Investing Cash Flow	$409.0M	↓ 256.7%
Financing Cash Flow	$-1.5B	↓ 34.05%

	FY22	Y/Y Change
Operating Cash Flow	$-728.0M	↓ 151.05%
Investing Cash Flow	$-303.0M	↓ 174.08%
Financing Cash Flow	$-474.0M	↓ 68.67%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$268.8M	↑ 74.53%
Investing Cash Flow	$-30.0M	↓ 61.54%
Financing Cash Flow	$-120.0M	↓ 15.49%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$282.0M	↑ 4.92%
Investing Cash Flow	$-2.0B	↑ 6556.67%
Financing Cash Flow	$1.8B	↓ 1613.33%

Bausch Health Companies Technicals Summary

Sell

Neutral

Buy

Bausch Health Companies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bausch Health Companies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bausch Health Companies Inc	-16.98%	22.85%	0.93%	-68.56%	-75.0%
Neurocrine Biosciences Inc.	0.95%	-5.9%	3.78%	55.59%	17.86%
Haleon Plc Spon Ads	5.28%	15.21%	19.0%	31.85%	31.85%
Zoetis Inc.	1.85%	3.41%	-10.25%	-23.75%	40.1%
Viatris Inc.	-1.39%	22.71%	25.86%	1.59%	-21.97%
Catalent, Inc.	6.73%	12.99%	59.5%	-49.36%	19.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bausch Health Companies Inc	71.75	NA	0.63	3.75	-23.05	0.04	NA	-3.19
Neurocrine Biosciences Inc.	34.48	34.48	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.44	28.44	1.72	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	33.15	33.15	2.48	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	518.67	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bausch Health Companies Inc	Hold	$3.1B	-75.0%	71.75	-1.88%
Neurocrine Biosciences Inc.	Buy	$13.1B	17.86%	34.48	17.21%
Haleon Plc Spon Ads	Buy	$43.7B	31.85%	28.44	10.75%
Zoetis Inc.	Buy	$79.7B	40.1%	33.15	26.55%
Viatris Inc.	Hold	$15.1B	-21.97%	224.4	-5.87%
Catalent, Inc.	Hold	$11.3B	19.07%	211.02	-9.34%

About Bausch Health Companies

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###

Organization	Bausch Health Companies
Employees	20270
CEO	Mr. Thomas J. Appio
Industry	Health Technology

Management People of Bausch Health Companies

Name	Title
Mr. Thomas J. Appio	CEO & Director
Ms. Seana Carson	Executive VP & General Counsel
Mr. Jean-Jacques Charhon	Executive VP & CFO
Mr. Mirza Dautbegovic	Executive VP & COO
Mr. Garen Sarafian	VP & Head of Investor Relations
Ms. Kathleen Fitzpatrick	Executive VP and Chief HR & Communications Officer
Mr. Cees Heiman	Senior Vice President of Europe & Canada
Mr. Donald Pearl	Senior Vice President of Ortho Dermatologics
Ms. Jiny Kim M.B.A.	Senior Vice President of Solta Medical
Ms. Aimee J. Lenar	Executive Vice President of US Pharma

Important FAQs about investing in Bausch Health Companies from India :

What is Bausch Health Companies share price today?

Bausch Health Companies (BHC) share price today is $7.58.

Can Indians buy Bausch Health Companies shares?

Yes, Indians can invest in the Bausch Health Companies (BHC) from India.

With INDmoney, you can buy Bausch Health Companies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bausch Health Companies at zero transaction cost.

How can I buy Bausch Health Companies shares from India?

It is very easy to buy Bausch Health Companies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bausch Health Companies be purchased?

Yes, you can buy fractional shares of Bausch Health Companies with INDmoney app.

What are the documents required to start investing in Bausch Health Companies stocks?

To start investing in Bausch Health Companies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.